Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...

When Jazz Pharmaceuticals' incoming CEO Renee Gala takes the reins at the drugmaker next week, she'll have a brand-new launch ...

Werewolf Therapeutics is transforming its brand awareness and clinical trial recruitment efforts with a new campaign. | ...

After a second Elevidys patient death from acute liver failure, Sarepta in July launched a major restructuring that involves ...

On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...

If you want to know where pharma's heading, it helps to be in the room when executives admit what they're worried about | ...

After beating AstraZeneca’s Calquence in quarterly revenue for the first time at the end of 2024, BeOne Medicines’ Brukinsa ...

Supreme Group said the deal deepens its expertise in rare disease and pharma and expands the creative and omnichannel ...

When Bayer CEO Bill Anderson launched his Dynamic Shared Ownership (DSO) layoff plan—designed to save 2 billion euros ($2.3 billion) in 2026—he said it would be completed by the “end of 2025 at the | ...

Raising awareness of medical products and services is a marathon, not a sprint, and Babson Diagnostics has therefore selected a star with plenty of stamina for a long-term partnership. | Raising ...

“We’ll be putting initially a small tariff on pharmaceuticals but in one year—one and a half years maximum—it’s going to go ...

In July, spending on TV ads for prescription drugs reached a low not seen since this time last year. | In July, spending on ...